MUMBAI, India, Oct. 31 -- Intellectual Property India has published a patent application (202431033327 A) filed by Indian Institute Of Science Education And Research, Kolkata, West Bengal, on April 26, 2024, for 'novel peptide based immune-checkpoint blockerfor breast cancer treatment.'
Inventor(s) include Sinha Roy, Rituparna; Tripathi, Archana; Chatterjee, Ananya; Gurung, Arun Bahadur; and Mallick, Argha Mario.
The application for the patent was published on Oct. 31, under issue no. 44/2025.
According to the abstract released by the Intellectual Property India: "There is provided an immune check point blocker protease stable peptide for breast cancer treatment selected from the group consisting of peptides having SEQ ID NO. 1, SEQ ID. NO. 2, SEQ ID NO. 3 and SEQ ID NO. 4. There is also provides a peptide composition for breast cancer treatment comprising a pharmaceutically effective amount of the said peptides."
Disclaimer: Curated by HT Syndication.
